Madhumita Ghosh | Retinal Degeneration and Diabetic retinopathy | Women Researcher Award

Profile:

Scopus

Orcid

Google Scholar

Education:

Dr. Madhumita Ghosh 🌐 embarked on her academic journey with a Ph.D. from Jadavpur University, Kolkata (1995-2001), marking the genesis of her profound expertise. Following this, she contributed as a Research Associate at AIIMS, New Delhi (2001-2002), and broadened her horizons with a Visiting Post Doctoral Fellowship at the National Eye Institute, NIH, Bethesda, USA (2002-2004). Returning to India, she continued her postdoctoral endeavors at the National Brain Research Center, New Delhi (2004-2008). 🧠 These diverse experiences laid the foundation for her illustrious career, positioning her as a seasoned researcher with a global perspective in the realm of neuroscience. 🌍👩‍🔬

Experience:

From 2008 to 2011, Dr. Madhumita Ghosh assumed the role of Senior Lecturer at the Amity Institute of Biotechnology, Amity University, Noida, India, contributing significantly to academic growth. 🎓 Transitioning seamlessly, she served as an Assistant Professor from 2011 to 2019, leaving an indelible mark on the institution’s biotechnology landscape. 🌱 Her dedication and prowess have been further acknowledged since 2019, as she currently holds the position of Associate Professor at the Amity Institute of Biotechnology. 🚀 Dr. Ghosh’s enduring commitment to education underscores her influential role in shaping the next generation of biotechnologists. 👩‍🏫🔬

Research Activity:

Dr. Madhumita P. Ghosh 🌟, an accomplished Associate Professor at Amity Institute of Biotechnology since 2019, boasts a stellar research portfolio. 🧪 Her impactful work includes a Department of Biotechnology grant in 2016, exploring lithium’s antiapoptotic properties against retinal ganglion cell degeneration. 🤖 She led a Department of Science and Technology project (2017-2020) on dopamine treatment in diabetic retinopathy, unraveling insights into angiogenesis. 🩸👁 Currently, she mentors a Ph.D. student in a project studying VEGF’s role using Trolox and CoQ10 against NMDA-induced toxicity. Her groundbreaking contributions to retinal research showcase her dedication and leadership in advancing eye health. 👩‍🔬🔍✨

Publications:

“Trolox aids coenzyme Q10 in neuroprotection against NMDA induced damage via upregulation of VEGF in rat model of glutamate excitotoxicity”

Authors: Upreti, S., Nag, T.C., Ghosh, M.P.

Year: 2024

Citation: Experimental Eye Research, 238, 109740

🧠👁✨

“Insulin-like growth factor-1 works synergistically with dopamine to attenuate diabetic retinopathy by downregulating vascular endothelial growth factor”

Authors: Upreti, S., Sen, S., Nag, T.C., Ghosh, M.P.

Year: 2022

Citation: Biomedicine and Pharmacotherapy, 149, 112868

🔄🌱👁

“Trolox assisted inhibition of glutamate excitotoxicity-mediated degeneration in retina”

Authors: Upreti, S., Ghosh, M.P.

Year: 2022

Citation: Contemporary Medical Biotechnology Research for Human Health, pp. 79–90

🧪👁🚫

“Rapid Electrochemical Quantification for In Vitro Release Trait of Ophthalmic Drug Loaded within Mucoadhesive Metal Organic Framework (MOF)”

Authors: Chansi, Upreti, Punya, Ghosh, M.P., Basu, T.

Year: 2021

Citation: ChemistrySelect, 6(12), pp. 3006–3012

⚡💧👁

“Mutations associated with retinopathies alter mitogen-activated protein kinase-induced phosphorylation of neural retina leucine-zipper”

Authors: Swain, P., Kumar, S., Patel, D., Ghosh, M., Swaroop, A.

Year: 2007

Citation: Molecular Vision, 13, pp. 1114–1120

🧬🔄👁

“Lack of fiber cell induction stops normal growth of rat lenses in organ culture”

Author: Ghosh, M.P., Zigler Jr., J.S.

Year: 2005

Citation: Molecular Vision, 11, pp. 901–908

🧪👁🔒

“A spontaneous mutation affects programmed cell death during development of the rat eye”

Authors: Sinha, D., Hose, S., Zhang, C., Ghosh, M.P., Lo, W.-K., Zigler Jr., J.S.

Year: 2005

Citation: Experimental Eye Research, 80(3), pp. 323–335

🌀💔👁